Assessing treatment outcomes in attention-deficit/hyperactivity disorder: A narrative review

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 14, Issue 6, 2012, Pages

  Epstein, Jeffery N ^a   Weiss, Margaret D ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; LISDEXAMFETAMINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; COGNITIVE THERAPY; COPING BEHAVIOR; EXECUTIVE FUNCTION; FUNCTIONAL DISEASE; HUMAN; LIFESPAN; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKILL; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84874908692     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.11r01336     Document Type: Article

References (163)

1. Visser SN, Bitsko RH, Danielson ML, et al; Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children-United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439-1443.
2. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723.
3. Fabiano GA, Pelham WE Jr, Coles EK, et al. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009;29(2):129-140.
4. Faraone SV. Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. 2009;34(12):678-694.
5. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71(6):754-763.
6. Majewicz-Hefley A, Carlson JS. A meta-analysis of combined treatments for children diagnosed with ADHD. J Atten Disord. 2007;10(3):239-250.
7. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10(1):67.
8. National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. London, UK: National Collaborating Centre for Mental Health; 2008.
9. American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033-1044.
10. S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
12. Buitelaar J, Medori R. Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants. Eur Child Adolesc Psychiatry. 2010;19(4):325-340.
13. Angold A, Costello EJ, Farmer EM, et al. Impaired but undiagnosed. J Am Acad Child Adolesc Psychiatry. 1999;38(2):129-137.
14. Pelham WE Jr, Fabiano GA, Massetti GM. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol. 2005;34(3):449-476.
15. Brown RT, Perwien A, Faries DE, et al. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clin Pediatr (Phila). 2006;45(9):819-827.
16. Brown TE. ADD/ADHD and impaired executive function in clinical practice. Curr Psychiatry Rep. 2008;10(5):407-411.
17. Barkley RA. Genetics of childhood disorders: XVII. ADHD, part 1: the executive functions and ADHD. J Am Acad Child Adolesc Psychiatry. 2000;39(8):1064-1068.
18. Kessler RC, Green JG, Adler LA, et al. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry. 2010;67(11):1168-1178.
19. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816-818.
20. American Psychiatric Association. DSM-5 development: attention deficit/hyperactivity disorder (314.0x). http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=383. Accessed June 19, 2012.
21. Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales, 5: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2003;42(9):1015-1037.
22. Madaan V, Daughton J, Lubberstedt B, et al. Assessing the efficacy of treatments for ADHD: overview of methodological issues. CNS Drugs. 2008;22(4):275-290.
23. McCarney SB. Early Childhood Attention Deficit Disorders Evaluation Scale, Technical Manual. Columbia, MO: Hawthorne Educational Services; 1995.
24. DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
25. Holland ML, Gimpel GA, Merrell KW. ADHD Symptoms Rating Scale Manual. Wilmington, DE: Wide Range; 2001.
26. Conners C. Conners' Rating Scales-Revised Technical Manual. North Tonawanda, NY: Multi-Health Systems; 1997.
27. J. The SNAP-IV Teacher and Parent Rating Scale. http://www.adhd.net/snap-iv-form.pdf. Accessed June 19, 2012.
28. Swanson J, Schuck S, Mann M, et al. Categorical and dimensional definitions and evaluations of symptoms of ADHD: the SNAP and the SWAN ratings scales. http://www.adhd.net/SNAP_SWAN.pdf. Accessed June 19, 2012.
29. Vanderbilt ADHD Diagnostic Parent Rating Scale. http://www.childrenshospital.vanderbilt.org/uploads/documents/DIAGNOSTIC_PARENT_RATING_SCALE(1).pdf. Accessed June 19, 2012.
30. Vanderbilt ADHD Diagnostic Teacher Rating Scale. http://www.brightfutures.org/mentalhealth/pdf/professionals/bridges/adhd.pdf. Accessed June 19, 2012.
31. JM. The Swan Rating Scale. http://www.klis.com/chandler/office/SWAN_SCALE.pdf. Accessed June 19, 2012.
32. Bussing R, Fernandez M, Harwood M, et al. Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment. 2008;15(3):317-328.
33. Lakes KD, Swanson JM, Riggs M. The reliability and validity of the English and Spanish Strengths and Weaknesses of ADHD and Normal Behavior Rating scales in a Preschool sample: continuum measures of hyperactivity and inattention [published online ahead of print August 1, 2011].J Atten Disord.
34. Wigal SB, Gupta S, Guinta D, et al. Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull. 1998;34(1):47-53.
35. Murray DW, Bussing R, Fernandez M, et al. Psychometric properties of teacher SKAMP ratings from a community sample. Assessment. 2009;16(2):193-208.
36. Holland ML, Gimpel GA, Merrell KW. Innovations in assessing ADHD: development, psychometric properties, and factor structure of the ADHD Symptoms Rating Scale (ADHD-SRS). J Psychopathol Behav Assess. 1998;20(4):307-332.
37. Goodman R. Psychometric properties of the Strengths and Difficulties Questionnaire. J Am Acad Child Adolesc Psychiatry. 2001;40(11):1337-1345.
38. Adler LA, Kessler RC, Spencer T. Adult ADHD Self-Report Scale-v1.1 (ASRS-v1.1) Symptom Checklist. World Health Organization. http://webdoc.nyumc.org/nyumc/files/psych/attachments/psych_adhd_checklist.pdf. Accessed June 19, 2012.
39. Kessler RC, Adler LA, Gruber MJ, et al. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52-65.
40. Conners CK, Erhart D, Sparrow E. Conners' Adult ADHD Rating Scales, Technical Manual. New York, NY: Multi-Health Systems Inc; 1999.
41. Conners CK, Erhardt D, Epstein JN, et al. Self-ratings of ADHD symptoms in adults I: factor structure and normative data. J Atten Disord. 1999;3(3):141-151.
42. Weiss MD, Gadow K, Wasdell MB. Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006;67(suppl 8):38-45.
43. Erhardt D, Epstein JN, Conners CK, et al. Self-ratings of ADHD symptoms in adults, 2: reliability, validity, and diagnostic sensitivity. J Atten Disord. 1999;3(3):153-158.
44. Adler LA, Faraone SV, Spencer TJ, et al. The reliability and validity of self- and investigator ratings of ADHD in adults. J Atten Disord. 2008;11(6):711-719.
45. Van Voorhees EE, Hardy KK, Kollins SH. Reliability and validity of self- and other-ratings of symptoms of ADHD in adults. J Atten Disord. 2011;15(3):224-234.
46. Barkley RA, Murphy KR. Attention-Deficit Hyperactivity Disorder: A Clinical Workbook. 2nd ed. New York, NY: Guilford Press; 1998.
47. Gomez R. Item response theory analyses of adult self-ratings of the ADHD symptoms in the Current Symptoms Scale. Assessment. 2011;18(4):476-486.
48. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885-890.
49. Barkley RA. Barkley Adult ADHD Rating Scale-IV (BAARS-IV). New York, NY: Guilford Press; 2011.
50. Zucker M, Morris MK, Ingram SM, et al. Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. Psychol Assess. 2002;14(4):379-389.
51. Safren SA, Otto MW, Sprich S, et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43(7):831-842.
52. Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010;304(8):875-880.
53. Emilsson B, Gudjonsson G, Sigurdsson JF, et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry. 2011;11(1):116.
54. Virta M, Salakari A, Antila M, et al. Short cognitive behavioral therapy and cognitive training for adults with ADHD-a randomized controlled pilot study. Neuropsychiatr Dis Treat. 2010;6:443-453.
55. Stevenson CS, Stevenson RJ, Whitmont S. A self-directed psychosocial intervention with minimal therapist contact for adults with attention deficit hyperactivity disorder. Clin Psychol Psychother. 2003;10(2):93-101.
56. Stevenson CS, Whitmont S, Bornholt L, et al. A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2002;36(5):610-616.
57. Barbaresi WJ, Katusic SK, Colligan RC, et al. Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr. 2007;28(4):265-273.
58. DuPaul GJ, McGoey KE, Eckert TL, et al. Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning. J Am Acad Child Adolesc Psychiatry. 2001;40(5):508-515.
59. Solanto MV, Pope-Boyd SA, Tryon WW, et al. Social functioning in predominantly inattentive and combined subtypes of children with ADHD. J Atten Disord. 2009;13(1):27-35.
60. Murray-Close D, Hoza B, Hinshaw SP, et al. Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol. 2010;22(4):785-802.
61. Blase SL, Gilbert AN, Anastopoulos AD, et al. Self-reported ADHD and adjustment in college: cross-sectional and longitudinal findings. J Atten Disord. 2009;13(3):297-309.
62. Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524-540.
63. Eakin L, Minde K, Hechtman L, et al. The marital and family functioning of adults with ADHD and their spouses. J Atten Disord. 2004;8(1):1-10.
64. Adler LA, Spencer TJ, Levine LR, et al. Functional outcomes in the treatment of adults with ADHD. J Atten Disord. 2008;11(6):720-727.
65. Waxmonsky JG, Waschbusch DA, Pelham WE, et al. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010;71(11):1535-1551.
66. Retz W, Rosler M, Ose C, et al. Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry. 2010;13(1):48-59.
67. Bird HR, Shaffer D, Fisher P, et al. The Columbia Impairment Scale (CIS): pilot findings on a measure of global impairment for children and adolescents. Int J Methods Psychiatr Res. 1993;3:167-176.
68. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull. 1997;33(1):13-16.
69. Gresham FM, Elliott S. Social Skills Rating System Manual. Circle Pines, MN: American Guidance Service; 1990.
70. DuPaul GJ, Rapport MD, Perriello LM. Teacher ratings of academic skills: the development of the Academic Performance Rating Scale. School Psych Rev. 1991;20:284-300.
71. Academic Performance Rating Scale. www.excellenceforchildandyouth.ca/sites/default/files/meas_attach/Academic_Performance_Rating_Scale_(APRS).pdf Accessed June 19, 2012.
72. Gresham FM, Elliott SN, Cook CR, et al. Cross-informant agreement for ratings for social skill and problem behavior ratings: an investigation of the Social Skills Improvement System-Rating Scales. Psychol Assess. 2010;22(1):157-166.
73. Fabiano GA, Pelham WE Jr, Waschbusch DA, et al. A practical measure of impairment: psychometric properties of the Impairment Rating Scale in samples of children with attention deficit hyperactivity disorder and two school-based samples. J Clin Child Adolesc Psychol. 2006;35(3):369-385.
74. Canadian ADHD Resource Alliance. CADDRA ADHD Assessment Toolkit Formse. http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011_Toolkit.pdf. Accessed June 26, 2012.
75. Weiss MD, Dickson R, Wasdell MB, et al. Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P). Presented at: American Psychiatric Association 158th Annual Meeting; May 21-26, 2005; Atlanta, GA.
76. Weiss MD, Brooks BL, Iverson GL, et al. Reliability and Validity of the Weiss Functional Impairment Rating Scale. Presented at: World Psychiatric Association; September 20-23, 2007; Shanghai, China.
77. SDQ Information for researchers and professionals about the Strengths & Difficulties Questionnaires. 2012. http://www.sdqinfo.com/a0.html. Updated January 1, 2012. Accessed June 12, 2012.
78. Van der Oord S, Prins PJM, Oosterlaan J, et al. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev. 2008;28(5):783-800.
79. Wilens TE, Hammerness P, Martelon M, et al. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010;71(5):548-556.
80. Saylor K, Williams DW, Schuh KJ, et al. Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD. Curr Med Res Opin. 2010;26(9):2087-2095.
81. Epstein JN, Langberg JM, Lichtenstein PK, et al. Attention-deficit/hyperactivity disorder outcomes for children treated in community-based pediatric settings. Arch Pediatr Adolesc Med. 2010;164(2):160-165.
82. Peterson K, McDonagh MS, Fu R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl). 2008;197(1):1-11.
83. Danckaerts M, Sonuga-Barke EJ, Banaschewski T, et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry. 2010;19(2):83-105.
84. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004;114(5):e541-e547.
85. Perwien AR, Kratochvil CJ, Faries DE, et al. Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? J Child Adolesc Psychopharmacol. 2006;16(6):713-724.
86. Hoza B, Gerdes AC, Hinshaw SP, et al. Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol. 2004;72(3):382-391.
87. Topolski TD, Edwards TC, Patrick DL, et al. Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord. 2004;7(3):163-173.
88. Brown TE, Landgraf JM. Improvements in executive function correlate with enhanced performance and functioning and health-related quality of life: evidence from 2 large, double-blind, randomized, placebo-controlled trials in ADHD. Postgrad Med. 2010;122(5):42-51.
89. Chao CY, Gau SS, Mao WC, et al. Relationship of attention-deficit-hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men. Psychiatry Clin Neurosci. 2008;62(4):421-426.
90. CHQ. Child Health Questionnaire. healthact chq. http://www.healthact.com/pdf/surveys/chq.pdf. Accessed June 19, 2012.
91. Child Health and Illness Profile. Child. Johns Hopkins University. http://www.childhealthprofile.org/index.asp?pageid=49. Accessed June 19, 2012.
92. Riley AW, Forrest CB, Rebok GW, et al. The Child Report Form of the CHIP-Child Edition: reliability and validity. Med Care. 2004;42(3):221-231.
93. Child Health and Illness Profile: adolescent. Johns Hopkins University: http://www.childhealthprofile.org/index.asp?pageid=50. Accessed June 19, 2012.
94. Riley AW, Coghill D, Forrest CB, et al; ADORE Study Group. Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. Eur Child Adolesc Psychiatry. 2006;15(suppl 1):i63-i71.
95. Landgraf J. Child Health Questionnaire (CHQ): A User's Manual. Boston, MA: Integrated Therapeutics Group; 1996.
96. Rentz AM, Matza LS, Secnik K, et al. Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder. Qual Life Res. 2005;14(3):719-734.
97. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126-139.
98. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800-812.
99. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), 1: conceptual framework and item selection. Med Care. 1992;30(6):473-483.
100. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160-164.
101. Weiss MD, Gibbins C, Goodman DW, et al. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010;71(4):381-390.
102. AIM-C. ADHD Impact Module-Child. healthact chq:2012. http://www.healthact.com/pdf/surveys/aim-c.pdf. Accessed June 18, 2012.
103. Landgraf JM, Rich M, Rappaport L. Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med. 2002;156(4):384-391.
104. AIM-A. ADHD Impact Module-Adult. healthact chq. 2012: http://www.healthact.com/pdf/surveys/aim-a.pdf. Accessed June 18, 2012.
105. Landgraf JM. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord. 2007;11(3):351-362.
106. Brod M, Johnston J, Able S, et al. Validation of the Adult Attention-Deficit/Hyperactivity Disorder Quality-of-Life Scale (AAQOL): a disease-specific quality-of-life measure. Qual Life Res. 2006;15(1):117-129.
107. Matza LS, Johnston JA, Faries DE, et al. Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQOL). Qual Life Res. 2007;16(9):1511-1520.
108. Manos M, Frazier TW, Landgraf JM, et al. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system. Curr Med Res Opin. 2009;25(12):3001-3010.
109. Spencer TJ, Adler LA, Weisler RH, et al. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69(9):1437-1448.
110. Barkley RA. ADHD and the Nature of Self-Control. New York, NY: Guilford Press; 1997.
111. Barkley R. Driving risks in adults with ADHD: yet more evidence and a personal story. The ADHD Report. 2006;14(5):1-9.
112. Stein MA, Szumowski E, Blondis TA, et al. Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry. 1995;36(4):663-670.
113. Roizen NJ, Blondis TA, Irwin M, et al. Adaptive functioning in children with attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med. 1994;148(11):1137-1142.
114. Kubik JA. Efficacy of ADHD coaching for adults with ADHD. J Atten Disord. 2010;13(5):442-453.
115. Young S, Chadwick O, Heptinstall E, et al. The adolescent outcome of hyperactive girls: self-reported interpersonal relationships and coping mechanisms. Eur Child Adolesc Psychiatry. 2005;14(5):245-253.
116. Knouse LE, Safren SA. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am. 2010;33(3):497-509.
117. Newark PE, Stieglitz RD. Therapy-relevant factors in adult ADHD from a cognitive behavioural perspective. Atten Defic Hyperact Disord. 2010;2(2):59-72.
118. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales. Circle Pines, MN: American Guidance Service; 1984.
119. Sparrow SS, Cicchetti DV. Diagnostic uses of the Vineland Adaptive Behavior Scales. J Pediatr Psychol. 1985;10(2):215-225.
120. Bramham J, Young S, Bickerdike A, et al. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5):434-441.
121. Spirito A, Stark LJ, Williams C. Development of a brief coping checklist for use with pediatric populations. J Pediatr Psychol. 1988;13(4):555-574.
122. Saylor K, Buermeyer C, Sutton V, et al. The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder-Child Version: psychometric properties of an adaptive change instrument. J Child Adolesc Psychopharmacol. 2007;17(6):831-842.
123. Harrison PI, Oakland T. Manual for the ABAS-II. New York, NY: PsychCorp; 2003.
124. Wei Y, Oakland T, Algina J. Multigroup confirmatory factor analysis for the Adaptive Behavior Assessment System-II parent form, ages 5-21. Am J Ment Retard. 2008;113(3):178-186.
125. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3, pt 1):179-186.
126. Shallice T, Marzocchi GM, Coser S, et al. Executive function profile of children with attention deficit hyperactivity disorder. Dev Neuropsychol. 2002;21(1):43-71.
127. Loo SK, Humphrey LA, Tapio T, et al. Executive functioning among Finnish adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(12):1594-1604.
128. Seidman LJ. Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev. 2006;26(4):466-485.
129. Martel M, Nikolas M, Nigg JT. Executive function in adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1437-1444.
130. Boonstra AM, Oosterlaan J, Sergeant JA, et al. Executive functioning in adult ADHD: a meta-analytic review. Psychol Med. 2005;35(8):1097-1108.
131. Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18(3):485-503.
132. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. New York, NY: Oxford University Press; 2006.
133. Dubois B, Andrade K, Levy R. Executive dysfunction and neuropsychological testing. Handb Clin Neurol. 2008;89:35-52.
134. Logan GD, Schachar RJ, Tannock R. Impulsivity and inhibitory control. Psychol Sci. 1997;8(1):60-64.
135. Gioia GA, Isquith PK, Guy SC, et al. Behavior Rating Inventory of Executive Function. Child Neuropsychol. 2000;6(3):235-238.
136. Roth RM, Isquith PK, Gioia GA. Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Professional Manual. Lutz, FL: Psychological Assessment Resources; 2005.
137. Gioia GA, Isquith PK, Retzlaff PD, et al. Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychol. 2002;8(4):249-257.
138. Toplak ME, Bucciarelli SM, Jain U, et al. Executive functions: performance-based measures and the Behavior Rating Inventory of Executive Function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol. 2009;15(1):53-72.
139. Brown TE. Brown Attention-Deficit Hyperactivity Disorder Scales for Adolescent and Adults. 2nd ed. San Antonio, TX: The Psychological Corporation, Harcourt Assessment; 2001.
140. Brown TE. Executive functions and attention deficit hyperactivity disorder: implications of two conflicting views. Int J Disabil Dev Educ. 2006;53(1):35-46.
141. TE. The Brown Attention Deficit Disorder Scales. Journal of Occupational Psychology, Employment and Disability. 2003;5(2)29-31.
142. Barkley RA. Barkley Deficits in Executive Functioning Scale (BDEFS). New York, NY: Guilford Press; 2011.
143. Abikoff H, Gallagher R, eds. Assessment and remediation of organizational skills deficits in children with ADHD. McBurnett K, Pfiffner L, eds. Attention Deficit Hyperactivity Disorder: Concepts, Controversies, New Directions. New York, NY: Informa Healthcare USA; 2009.
144. Kaya F, Delen E, Ritter NL. Test review: Children's Organizational Skills Scales. J Psychoed Assess. 2012;30(2):205-208.
145. Biederman J, Petty CR, Fried R, et al. Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand. 2007;116(2):129-136.
146. Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(10):1730-1738.
147. Surman CB, Biederman J, Spencer T, et al. Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry. 2011;168(6):617-623.
148. Barkley RA. Deficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorder. J ADHD Relat Disord. 2010;1:5-37.
149. Hazel-Fernandez LA, Klorman R, Wallace JM, et al. Methylphenidate improves aspects of executive function in African American children with ADHD. J Atten Disord. 2006;9(4):582-589.
150. Turgay A, Ginsberg L, Sarkis E, et al. Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study. J Child Adolesc Psychopharmacol. 2010;20(6):503-511.
151. Bedard AC, Jain U, Johnson SH, et al. Effects of methylphenidate on working memory components: influence of measurement. J Child Psychol Psychiatry. 2007;48(9):872-880.
152. Bedard AC, Martinussen R, Ickowicz A, et al. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43(3):260-268.
153. Bedard AC, Tannock R. Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord. 2008;11(5):546-557.
154. McInnes A, Bedard AC, Hogg-Johnson S, et al. Preliminary evidence of beneficial effects of methylphenidate on listening comprehension in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17(1):35-49.
155. Brown TE, Brams M, Gao J, et al. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med. 2010;122(5):7-17.
156. Biederman J, Seidman LJ, Petty CR, et al. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(7):1150-1156.
157. Safren SA, Perlman CA, Sprich S, et al. Mastering Your Adult ADHD: A Cognitive-Behavioral Treatment Program-Therapist Guide. Oxford, UK: Oxford University Press; 2005.
158. Solanto MV. Cognitive-Behavioral Therapy for Adult ADHD: Targeting Executive Dysfunction. New York, NY: The Guilford Press; 2011.
159. Ramsay JR, Rostain AL. Cognitive-Behavioral Therapy for Adult ADHD: An Integrative Psychosocial and Medical Approach. New York, NY: Routledge; 2007.
160. Lavigne JV, Dulcan MK, Lebailly SA, et al. Can parent reports serve as a proxy for teacher ratings in medication management of attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2012;33(4):336-342.
161. Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60-73.
162. NICHQ Vanderbilt Assessment Follow-up, Parent Informant. http://www.nichq.org/toolkits_publications/complete_adhd/05VanFollowUp%20Parent%20Infor.pdf. Accessed August 10, 2012.
163. NICHQ Vanderbilt Assessment Follow-up, Teacher Informant. http://www.nichq.org/toolkits_publications/complete_adhd/06VanAssessFollowUpTeachInfor.pdf. Accessed August 10, 2012.